Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;97(8):903-912.
doi: 10.1038/labinvest.2017.51. Epub 2017 May 22.

Thymidine Phosphorylase Promotes Metastasis and Serves as a Marker of Poor Prognosis in Hepatocellular Carcinoma

Affiliations
Free article

Thymidine Phosphorylase Promotes Metastasis and Serves as a Marker of Poor Prognosis in Hepatocellular Carcinoma

Qiang Zhang et al. Lab Invest. .
Free article

Abstract

Hepatocellular carcinoma (HCC) ranks as one of the most common and lethal malignancies worldwide. A better understanding of the mechanism responsible for HCC metastasis will be helpful for the treatment of HCC patients. Thymidine phosphorylase (TP), a key enzyme that catalyzes the conversion of thymidine to thymine and deoxyribose-1-phosphate, was demonstrated to promote the invasion and metastasis of HCC in our study. Clinical retrospective analysis revealed that metastatic HCC tumor tissues have higher TP expression, and TP expression was significantly correlated with matrix metalloproteinase (MMP) 2 and 9 expression. Survival analysis revealed that TP expression was negatively correlated with the prognosis of HCC patients. Moreover, in vitro cell experiments confirmed that TP could promote the migration and invasion of HCC cells. In addition, MMP2 and MMP9 were activated by TP overexpression. Overall, this study suggests that TP promotes metastasis and may serve as a marker of poor prognosis in HCC. Thus, TP is a potential target for the treatment of HCC.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
    1. Circ Res. 2009 Jan 2;104(1):32-40 - PubMed
    1. Am J Med. 2008 Feb;121(2):119-26 - PubMed
    1. Biochemistry. 1985 Nov 19;24(24):6799-807 - PubMed
    1. Oncotarget. 2016 Apr 19;7(16):21952-67 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback